EUVIMEDEUVIMED entdecken
Open Access

SWAP70 Overexpression Protects Against Pathological Cardiac Hypertrophy in a TAK1‐Dependent Manner

Qiaofeng Qian iD, Fengjiao Hu, Wenjun Yu, Dewen Leng, Yang Li, Hongjie Shi, Dawei Deng iD, Kehan Ding, Chuan Liang iD, Jinping Liu iD

Journal of the American Heart Association · 2023

DOI: 10.1161/jaha.122.028628 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2023. Verfasst von Qiaofeng Qian und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery Zhongnan Hospital of Wuhan University Wuhan China. Hauptthemen laut MEDLINE: Cardiomegaly, Heart Failure. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pathological cardiac hypertrophy is regarded as a critical precursor and independent risk factor of heart failure, and its inhibition prevents the progression of heart failure. Switch‐associated protein 70 (SWAP70) is confirmed important in immunoregulation, cell maturation, and cell transformation. However, its role in pathological cardiac hypertrophy remains unclear. Methods and Results The effects of SWAP70 on pathological cardiac hypertrophy were investigated in Swap70 knockout mice and Swap70 overexpression/knockdown cardiomyocytes. Bioinformatic analysis combined with multiple molecular biological methodologies were adopted to elucidate the mechanisms underlying the effects of SWAP70 on pathological cardiac hypertrophy. Results showed that SWAP70 protein levels were significantly increased in failing human heart tissues, experimental transverse aortic constriction–induced mouse hypertrophic hearts, and phenylephrine‐stimulated isolated primary cardiomyocytes. Intriguingly, phenylephrine treatment decreased the lysosomal degradation of SWAP70 by disrupting the interaction of SWAP70 with granulin precursor. In vitro and in vivo experiments revealed that Swap70 knockdown/knockout accelerated the progression of pathological cardiac hypertrophy, while Swap70 overexpression restrained the cardiomyocyte hypertrophy. SWAP70 restrained the binding of transforming growth factor β‐activated kinase 1 (TAK1) and TAK1 binding protein 1, thus blocking the phosphorylation of TAK1 and downstream c‐Jun N‐terminal kinase/P38 signaling. TAK1 interacted with the N‐terminals (1–192) of SWAP70. Swap70 (193–585) overexpression failed to inhibit cardiac hypertrophy when the TAK1–SWAP70 interaction was disrupted. Either inhibiting the phosphorylation or suppressing the expression of TAK1 rescued the exaggerated cardiac hypertrophy induced by Swap70 knockdown.

Conclusions

SWAP70 suppressed the progression of cardiac hypertrophy, possibly by inhibiting the mitogen‐activated protein kinases signaling pathway in a TAK1‐dependent manner, and lysosomes are involved in the regulation of SWAP70 expression level.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CardiomegalyHeart FailureAnimalsHumansMiceDNA-Binding ProteinsGuanine Nucleotide Exchange FactorsMice, KnockoutMinor Histocompatibility AntigensMyocytes, CardiacNuclear ProteinsPhenylephrineSignal TransductionMAP Kinase Kinase Kinase 7

Stichwörter der Autor:innen

SWAP70cardiac hypertrophygranulin precursorheart failuremitogen‐activated protein kinases

Substanzen

DNA-Binding ProteinsGuanine Nucleotide Exchange FactorsMinor Histocompatibility AntigensNuclear ProteinsPhenylephrineMAP Kinase Kinase Kinase 7SWAP70 protein, humanSwap70 protein, mouse

Autor:innen und Institutionen

  • Department of Cardiovascular Surgery Zhongnan Hospital of Wuhan University Wuhan China.
  • Medical Science Research Centre Zhongnan Hospital of Wuhan University Wuhan China.
  • Hubei Provincial Engineering Research Center of Minimally Invasive Cardiovascular Surgery Wuhan China.
  • Wuhan Clinical Research Center for Minimally Invasive Treatment of Structural Heart Disease Wuhan China.

ORCID-Profile: Qiaofeng Qian, Dawei Deng, Chuan Liang, Jinping Liu

Zitieren

APA

Qian, Q., Hu, F., Yu, W., Leng, D., Li, Y., Shi, H., Deng, D., Ding, K., Liang, C., & Liu, J. (2023). SWAP70 Overexpression Protects Against Pathological Cardiac Hypertrophy in a TAK1‐Dependent Manner. Journal of the American Heart Association. https://doi.org/10.1161/jaha.122.028628

Vancouver

Qian Q, Hu F, Yu W, Leng D, Li Y, Shi H, et al. SWAP70 Overexpression Protects Against Pathological Cardiac Hypertrophy in a TAK1‐Dependent Manner. Journal of the American Heart Association. 2023. doi:10.1161/jaha.122.028628

BibTeX
@article{Qian2023,
  author = {Qian, Qiaofeng and Hu, Fengjiao and Yu, Wenjun and Leng, Dewen and Li, Yang and Shi, Hongjie and Deng, Dawei and Ding, Kehan and Liang, Chuan and Liu, Jinping},
  title = {SWAP70 Overexpression Protects Against Pathological Cardiac Hypertrophy in a TAK1‐Dependent Manner},
  journal = {Journal of the American Heart Association},
  year = {2023},
  doi = {10.1161/jaha.122.028628}
}
Kostenlos starten →